Allogene Therapeutics (ALLO) News Today $1.19 -0.01 (-0.83%) Closing price 07/3/2025 03:56 PM EasternExtended Trading$1.19 0.00 (0.00%) As of 07:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALLO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period ALLO - Allogene Therapeutics Inc Ownership - MorningstarJuly 3, 2025 | morningstar.comMALLO - Allogene Therapeutics Inc Dividends - MorningstarJune 27, 2025 | morningstar.comMAllogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 22, 2025 | marketbeat.comSystemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting-Edge Therapies | DelveInsightJune 18, 2025 | theglobeandmail.comZacks Research Issues Optimistic Forecast for ALLO EarningsJune 6, 2025 | marketbeat.comHC Wainwright Issues Optimistic Forecast for ALLO EarningsJune 4, 2025 | marketbeat.comQ1 Earnings Forecast for ALLO Issued By HC WainwrightJune 3, 2025 | marketbeat.comAllogene Therapeutics Presents Promising Phase 1 Data for ALLO-316 in Renal Cell CarcinomaJune 2, 2025 | msn.comBank of America Corp DE Buys 579,818 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO)June 2, 2025 | marketbeat.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) Shares Sold by Jane Street Group LLCJune 2, 2025 | marketbeat.comAllogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCOJune 1, 2025 | globenewswire.comAllogene Therapeutics: Buying Around A Potential ASCO Lazarus MomentMay 29, 2025 | seekingalpha.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Rating of "Moderate Buy" by AnalystsMay 29, 2025 | marketbeat.comAllogene Therapeutics: Still Looking Shaky, But Looking To Turn The Corner (Rating Upgrade)May 28, 2025 | seekingalpha.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) Shares Purchased by Two Sigma Advisers LPMay 27, 2025 | marketbeat.comAllogene shares update on CAR T-cell therapies at ASCO meetingMay 24, 2025 | investing.comAllogene Therapeutics Announces Participation in Upcoming Investor ConferencesMay 23, 2025 | globenewswire.comAllogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-CelMay 22, 2025 | globenewswire.comUndervalued Opportunities: 3 Penny Stocks With Market Caps Above $30MMay 22, 2025 | finance.yahoo.comBNP Paribas Financial Markets Boosts Holdings in Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 20, 2025 | marketbeat.comResearch Analysts Set Expectations for ALLO Q2 EarningsMay 20, 2025 | marketbeat.comRaiffeisen Bank International AG Invests $903,000 in Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 19, 2025 | marketbeat.comAllogene Therapeutics (NASDAQ:ALLO) Stock Rating Lowered by Citizens JmpMay 16, 2025 | marketbeat.comRobert W. Baird Issues Pessimistic Forecast for Allogene Therapeutics (NASDAQ:ALLO) Stock PriceMay 16, 2025 | marketbeat.comPatient Square Capital LP Makes New $3.17 Million Investment in Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 16, 2025 | marketbeat.comAllogene Therapeutics falls after trial delay, rating downgrade post Q1 resultsMay 15, 2025 | msn.comAllogene extends cash runway into 2027 while prioritizing ALPHA3 and clinical momentumMay 14, 2025 | msn.comAllogene Therapeutics Reports First Quarter 2025 Financial Results and Business UpdateMay 14, 2025 | finance.yahoo.comAllogene Therapeutics, Inc. (ALLO) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comAllogene Therapeutics Reports First Quarter 2025 Financial Results and Business UpdateMay 13, 2025 | globenewswire.comDimensional Fund Advisors LP Raises Stock Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 13, 2025 | marketbeat.com6ALLO : Allogene Therapeutics's Earnings OutlookMay 12, 2025 | benzinga.comIs Allogene Therapeutics, Inc. (ALLO) the Low Risk High Reward Stock Set to Triple by 2030?May 9, 2025 | uk.finance.yahoo.com10 Low Risk High Reward Stocks Set to Triple by 2030May 9, 2025 | insidermonkey.comSynnovation Therapeutics Announces the Appointment of Rafael G. Amado, M.D., to Its Board of DirectorsMay 8, 2025 | finance.yahoo.comAllogene Therapeutics Inc.May 7, 2025 | barrons.comAllogene Therapeutics Inc.May 7, 2025 | barrons.comAllogene Therapeutics (ALLO) Projected to Post Earnings on MondayMay 7, 2025 | marketbeat.comAllogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business UpdateMay 6, 2025 | globenewswire.comPrice T Rowe Associates Inc. MD Sells 353,171 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 6, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Invests $802,000 in Allogene Therapeutics, Inc. (NASDAQ:ALLO)May 5, 2025 | marketbeat.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 5, 2025 | marketbeat.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) Shares Bought by Barclays PLCMay 5, 2025 | marketbeat.com3,448,275 Shares in Allogene Therapeutics, Inc. (NASDAQ:ALLO) Bought by Foresite Capital Management VI LLCApril 30, 2025 | marketbeat.comLynx1 Capital Management LP Buys 4,672,349 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO)April 29, 2025 | marketbeat.comXTX Topco Ltd Buys Shares of 158,537 Allogene Therapeutics, Inc. (NASDAQ:ALLO)April 26, 2025 | marketbeat.comAllogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst institutional investors who own 59%April 25, 2025 | finance.yahoo.comAnnie Yoshiyama Sells 9,601 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO) StockApril 24, 2025 | insidertrades.comAllogene Therapeutics to present updated ALLO-316 results at ASCO meetingApril 24, 2025 | markets.businessinsider.comCentury Therapeutics (IPSC) Gets a Hold from William BlairApril 23, 2025 | markets.businessinsider.com Get Allogene Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLO and its competitors with MarketBeat's FREE daily newsletter. Email Address ALLO Media Mentions By Week ALLO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALLO News Sentiment▼0.000.58▲Average Medical News Sentiment ALLO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALLO Articles This Week▼14▲ALLO Articles Average Week Get Allogene Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELVN News Today NTLA News Today AKBA News Today COLL News Today ARDX News Today PHVS News Today SYRE News Today MLYS News Today ZYME News Today NRIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALLO) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
